Want to join the conversation?
For 1Q17, $KORS expects total revenue to be between $940-950MM, which includes a planned reduction in wholesale shipments, and comparable sales to decrease in the mid-single digit range. Non-GAAP diluted EPS is expected to be $0.70-0.74, excluding one-time costs and GAAP diluted EPS is expected to be $0.62-0.66, including one-time costs for 1Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?